Monash IVF is well positioned to benefit from growing social acceptance of infertility therapies.
We have revisited our forecast assumptions following yesterday’s trading update from IVF peer no-moat Virtus Health, and have reduced our fair value estimate for no-moat Monash IVF Group to AUD 2.00 per share from AUD 2.10. While we remain comfortable with our long-term growth rate for the IVF market, we now see increased competition that leads us to lower our pricing assumptions to 2.0% per year (from 3.5% previously) for the company’s IVF business. Our more positive outlook on pricing power in...Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.